The Arizona Republic discusses the move towards business realities by many medical research centers, including those working on aging and age-related diseases. This is a very good thing to see; this short of shift happens as a field becomes more legitimate and profitable therapies are seen as being closer to hand. It opens up reserves of funding that would otherwise go elsewhere. It encourages faster development and commercialization of new medicines and therapies. All in all, it should make us all very happy to see more articles like this in print!